Home
NICE Guidance
Conditions and diseases
Cancer
Colorectal cancer
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
Technology appraisal guidance [TA118]
Published:
24 January 2007
Last updated:
01 January 2012
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
Title
Year published
Impact Level
No results could be found